Aeon Biopharma Inc (AEON) Stock Price, Quote & News

Company Profile

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceu...

Industry: Biotechnology

Sector: Healthcare

Phone: 949 354 6499

Website: www.aeonbiopharma.com

Address:

5 Park Plaza, Suite 1750, Irvine, United States

TWITLIEDETECTOR Apr. 25 at 3:52 AM

$AEON i follow a lot of stocks. you may have a better chance at GUTS for a good return. it’s half the price of AEON. Look close, it’s a nice and gradual bullish trend. i am not just pumping. i did my research. i don’t own any stocks. i’ve been waiting to see if it got up into the .60 cent range. been following it since .42

1 · Reply

TWITLIEDETECTOR Apr. 22 at 4:10 AM

$AEON i did a lot of reading on this company. this conference is suppose to be for big announcements. i’m not holding my breath.

3 · Reply

ka1954 Apr. 21 at 7:38 PM

$AEON 1st time AEON went to 1.07 then down, then it went to 1.42 then donw, then it went 1.45 then down, this time do we see $2 atleast ?

0 · Reply

TWITLIEDETECTOR Apr. 20 at 11:32 PM

$AEON pathetic. trying to hit the 1.09 before the conference

1 · Reply

ka1954 Apr. 20 at 2:02 PM

$AEON come on just give us 100%+ or so finally. sick of holding for this so long only to see it go up and down every week

0 · Reply

Eight88 Apr. 17 at 6:00 PM

$AEON have a feeling someone on their board said... "get this sh*t up over a dollar before we attend the conference next week."

2 · Reply

BryceyBoy Apr. 16 at 12:51 PM

$AEON We gonna go back above a dollar today?

1 · Reply

VinWeezel Apr. 15 at 4:20 PM

$AEON volume city. Weird.

1 · Reply

luminouslumens Apr. 15 at 3:03 PM

$AEON 🧐

0 · Reply

BryceyBoy Apr. 15 at 12:22 PM

$AEON Still holding strong

0 · Reply

AEON Biopharma Sets Annual Shareholder Meeting

Apr 3, 2026, 4:10 PM EDT - 22 days ago

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

Apr 3, 2026, 4:05 PM EDT - 22 days ago

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards

Mar 30, 2026, 4:05 PM EDT - 26 days ago

AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program

Jan 21, 2026, 4:05 PM EST - 3 months ago

AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions

Dec 15, 2025, 4:05 PM EST - 4 months ago

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong

Nov 20, 2025, 8:30 AM EST - 5 months ago

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling

Nov 14, 2025, 8:30 AM EST - 5 months ago

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

Nov 13, 2025, 8:30 AM EST - 5 months ago

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

Oct 1, 2025, 8:00 AM EDT - 7 months ago

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

Aug 12, 2025, 4:05 PM EDT - 9 months ago

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update

May 19, 2025, 4:05 PM EDT - 1 year ago

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025

May 14, 2025, 4:05 PM EDT - 1 year ago

AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

Apr 25, 2025, 4:05 PM EDT - 1 year ago

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Apr 21, 2025, 4:05 PM EDT - 1 year ago

AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer

Mar 27, 2025, 4:05 PM EDT - 1 year ago

AEON Biopharma Announces CEO Transition

Mar 24, 2025, 4:05 PM EDT - 1 year ago

AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 4, 2025, 8:00 AM EST - 1 year ago

AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference

Feb 24, 2025, 2:00 PM EST - 1 year ago

AEON Biopharma, Inc. Announces Reverse Stock Split

Feb 7, 2025, 4:05 PM EST - 1 year ago

AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Jan 7, 2025, 9:37 AM EST - 1 year ago

AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering

Jan 3, 2025, 8:02 PM EST - 1 year ago

AEON Biopharma, Inc. Announces Launch of Proposed Public Offering

Nov 13, 2024, 4:05 PM EST - 1 year ago

AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Aug 19, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 12, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

May 29, 2024, 8:00 AM EDT - 2 years ago

AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan

May 14, 2024, 4:05 PM EDT - 2 years ago

AEON Biopharma Reports First Quarter 2024 Financial Results

May 9, 2024, 8:00 AM EDT - 2 years ago

AEON Biopharma Provides Update on Development Pipeline

May 3, 2024, 7:00 AM EDT - 2 years ago

AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine

Mar 30, 2024, 10:53 PM EDT - 2 years ago

CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants

Mar 29, 2024, 4:15 PM EDT - 2 years ago

AEON Biopharma Announces Redemption of Public Warrants

Mar 29, 2024, 3:45 PM EDT - 2 years ago

AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 19, 2024, 4:30 PM EDT - 2 years ago

AEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine

Mar 19, 2024, 4:29 PM EDT - 2 years ago

AEON Biopharma Announces $15 Million Financing Transaction and Termination of Forward Purchase Agreements

Jan 18, 2024, 4:05 PM EST - 2 years ago

AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference

Dec 12, 2023, 8:00 AM EST - 2 years ago

AEON Biopharma Completes Enrollment in Phase 2 Study of ABP-450 (prabotulinumtoxinA) for Preventive Treatment of Chronic Migraine

Nov 13, 2023, 8:15 AM EST - 2 years ago

AEON Biopharma Reports Third Quarter 2023 Financial Results

Oct 19, 2023, 4:05 PM EDT - 2 years ago

AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine

Aug 29, 2023, 8:00 AM EDT - 2 years ago

AEON Biopharma Presents Positive Results from Phase 2 Clinical Trial of ABP-450 (prabotulinumtoxinA) in Cervical Dystonia at the International Parkinson and Movement Disorders Society Congress®

Aug 24, 2023, 8:00 AM EDT - 2 years ago

AEON Biopharma Receives Notice of Allowance from USPTO for a Patent Covering Use of Botulinum Toxins to Treat Migraine Headache

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Strathspey Crown Holdings Group, LLC Provides Clarifying Statement Regarding Form 4 Filing with SEC for Holdings in AEON Biopharma

Jul 24, 2023, 7:00 AM EDT - 2 years ago

AEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline Update

TWITLIEDETECTOR Apr. 25 at 3:52 AM

1 · Reply

TWITLIEDETECTOR Apr. 22 at 4:10 AM

$AEON i did a lot of reading on this company. this conference is suppose to be for big announcements. i’m not holding my breath.

3 · Reply

ka1954 Apr. 21 at 7:38 PM

$AEON 1st time AEON went to 1.07 then down, then it went to 1.42 then donw, then it went 1.45 then down, this time do we see $2 atleast ?

0 · Reply

TWITLIEDETECTOR Apr. 20 at 11:32 PM

$AEON pathetic. trying to hit the 1.09 before the conference

1 · Reply

ka1954 Apr. 20 at 2:02 PM

$AEON come on just give us 100%+ or so finally. sick of holding for this so long only to see it go up and down every week

0 · Reply

Eight88 Apr. 17 at 6:00 PM

$AEON have a feeling someone on their board said... "get this sh*t up over a dollar before we attend the conference next week."

2 · Reply

BryceyBoy Apr. 16 at 12:51 PM

$AEON We gonna go back above a dollar today?

1 · Reply

VinWeezel Apr. 15 at 4:20 PM

$AEON volume city. Weird.

1 · Reply

luminouslumens Apr. 15 at 3:03 PM

$AEON 🧐

0 · Reply

BryceyBoy Apr. 15 at 12:22 PM

$AEON Still holding strong

0 · Reply

RaiderNation5413 Apr. 14 at 8:17 PM

$AEON still accumulating, and that average is looking better. Am I the only fool hangin' around? Conference is coming.

1 · Reply

TWITLIEDETECTOR Apr. 14 at 4:27 AM

$AEON someone was fucking with this stock today. don’t forget about the conference coming up. they have to pump it over the ol $1.09

0 · Reply

TWITLIEDETECTOR Apr. 13 at 10:56 PM

$AEON they don’t care about retail. those pumps were wrong. stock lacks liquidity

0 · Reply

TWITLIEDETECTOR Apr. 13 at 4:40 AM

$AEON anyone left here? almost worth buying back in soon. lots of support at .80.

1 · Reply

TWITLIEDETECTOR Apr. 10 at 2:51 AM

$AEON yikes .83 if they don’t pump between now and the conference the conference could be the pump

0 · Reply

Traidn Apr. 9 at 3:49 PM

$AEON So we're 20% below the previous thin red line of 1.09. Looks like the the one getting f______d is your account. Maybe I'm a buyer at 5 cents, but this looks insolvent. And the bulls are rude.

1 · Reply

TWITLIEDETECTOR Apr. 7 at 10:19 PM

$AEON when the artificial pumping starts again that may be a good sign

1 · Reply

Traidn Apr. 7 at 6:51 PM

$AEON look at volume, this ticker almost illiquid.

0 · Reply

HalEugene Apr. 4 at 8:49 PM

$AEON Just read through all the information presented........

2 · Reply

Traidn Apr. 4 at 4:22 PM

$AEON 🚨🚨🚨 https://intellectia.ai/news/stock/aeon-biopharma-faces-listing-compliance-risk

0 · Reply

Traidn Apr. 4 at 3:46 PM

$AEON 🩸🩸🩸 https://www.bitget.com/news/detail/12560605335600

0 · Reply

Traidn Apr. 4 at 3:45 PM

$AEON Race to the bottom. Maybe I'm not a buyer at 5 cents. https://cbonds.com/news/3260807/

0 · Reply

Market Cap	26.57M
Revenue (ttm)	0.00
Net Income (ttm)	-39.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	35,800
Avg Vol	107,610
Day's Range	N/A - N/A
Shares Out	25.30M
Stochastic %K	76%
Beta	0.74
Analysts	Strong Sell
Price Target	$6.10